Nanoformulated Recombinant Human Myelin Basic Protein and Rituximab Modulate Neuronal Perturbations in Experimental Autoimmune Encephalomyelitis in Mice

INTRODUCTION: Rituximab (RTX) and recombinant human myelin basic protein (rhMBP) were proven to be effective in ameliorating the symptoms of multiple sclerosis (MS). In this study, a nanoformulation containing rhMBP with RTX on its surface (Nano-rhMBP-RTX) was prepared and investigated in comparison...

Descripción completa

Detalles Bibliográficos
Autores principales: Saad, Muhammed A, Eissa, Noha M, Ahmed, Mohammed A, ElMeshad, Aliaa N, Laible, Götz, Attia, Ahmed S, Al-Ghobashy, Medhat A, Abdelsalam, Rania M, Al-Shorbagy, Muhammad Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464642/
https://www.ncbi.nlm.nih.gov/pubmed/36105617
http://dx.doi.org/10.2147/IJN.S359114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464642/
https://www.ncbi.nlm.nih.gov/pubmed/36105617
http://dx.doi.org/10.2147/IJN.S359114

Ejemplares similares